BERKSHIRE ASSET MANAGEMENT LLC/PA - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 25 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BERKSHIRE ASSET MANAGEMENT LLC/PA ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q2 2022$392,000
-23.7%
189,048
+3.8%
0.03%
-18.8%
Q1 2022$514,000
-39.6%
182,1410.0%0.03%
-38.5%
Q4 2021$851,000
+80.3%
182,141
+3.4%
0.05%
+62.5%
Q3 2021$472,000
-2.9%
176,185
+3.1%
0.03%
-3.0%
Q2 2021$486,000
-3.0%
170,830
+3.2%
0.03%
-10.8%
Q1 2021$501,000
+2.7%
165,4950.0%0.04%
-2.6%
Q4 2020$488,000
-18.3%
165,495
+0.6%
0.04%
-38.7%
Q1 2020$597,000
+370.1%
164,495
+485.4%
0.06%
+100.0%
Q3 2013$127,000
-14.2%
28,100
-3.1%
0.03%
-24.4%
Q2 2013$148,00029,0000.04%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q2 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders